Oncothyreon HomeContactSite MapGlossary
Investors
 
Stock Information
NASDAQ: ONTY
$4.70   + 0.04
Nov 20, 2009
4:00 PM ET
Quotes delayed at least 20 minutes. Information provided by eSignal.
Stock Information
Analyst Coverage

Firm Analyst
Janney Montgomery Scott LLC   Brian Rye
Rodman & Renshaw   Navdeep Jaikaria
Boenning & Scattergood   Derek Jellinek

Oncothyreon is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding Oncothyreon's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Oncothyreon or its management. Oncothyreon does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

return to top ^

About Oncothyreon | Pipeline | Clinical Trials | Business Development | Investors | News & Events